Research Article

Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization

Volume: 2 Number: 3 September 30, 2017
EN

Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization

Abstract

Background: E. coli infection is considered as an important bacterial problem associated with significant economic losses and usually associated with a variety of disease conditions, including acute septicaemia, haemorrhagic enteritis, pericariditis, salpingitis and complicated air saculitis.  These considerations suggest that control of E. coli by vaccination could be of great value especially live vaccine that based on defined mutations that impair and non-revering virulence.

Material and Methods: Wild type O78 strain, Live O78 aroA gene deleted vaccine and Live O78 crp gene deleted vaccine were used to accomplish this study. Phenotypic characterization was adopted by studying the cultural, biochemical and serological properties. Also genotypic characterization was studied for 16S rRNA, aroA and crp genes.

Results: Growth pattern on different media differed among the used strains as the wild type and Δ aroA mutant were nearly similar while the Δ crp mutant strain was greatly differed.  Biochemically the difference between the wild-type and Δ aroA mutant was inability of mutant strain to produce arginine dihydrase (ADH) and fermentation of saccharose. On the other hand the Δ crp mutant failed to produce ADH and to ferment any of the carbohydrates except glucose. A successful amplification of the 16S rRNA gene at 585 bp was detected with the all tested strains while was 1206 bp with only wild type and Δ crp mutant strain when aroA gene primers were used. Regarding crp genes, the amplified products was at 1029 bp with the wild and Δ aroA mutant but not with Δ crp mutant strains.

Conclusion: Findings of this study prove the use of methods based on molecular techniques like PCR to differentiate between different types of E. coli either wild or vaccinal mutant type strains. Also it may help in exclusion or proving the return back to virulence of the mutant vaccinal strains.

Keywords

References

  1. 1. De Silveira WD, Lancellotti M, Ferreira A, Solferini VN, De Castro AFP, et al. Determination of the clonal structure of avian E. coli strains by isoenzyme and ribotyping analysis. J Vet Med. B, Infectious diseases and Veterinary Public Health. 2003; 50: 63-69.
  2. 2. Prukner E. Frequency and epidemiological significance of virulent Escherichia coli strains in dead poultry. Vet Archive. 1986; 56: 227-237.
  3. 3. Cloud S S, Rosenberger JK, Fries PA, Wilson RA, Odor EM. In-vitro and in-vivo characterization of avian Escherichia coli I: serotypes, metabolic activity and antibiotic sensitivity. Avian Dis. 1985; 29: 1084 -1093.
  4. 4. Chart H, Smith HR, La Ragione R M and Woodward M J. An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5α, and EQ1. J Appl Microbiol. 2000; 89: 1048 - 1058.
  5. 5. Formmer AP , Freildlin R , Litner G, Chaffer M and Heller ED. Expermintal vaccination of young chickens with alive non-pathogenic strain of Escherichia coli. Avian Path. 1994; 23: 425-433.
  6. 6. Fasaei BN, Salehi TZ, Tadjbakhsh H, Firuzi R, Casadesus J. Construction of genetically defined aro A mutant of a native E. coli O78:K80 isolated from avian colibacillosis, in Iran. Comp Clin Pathol. 2009; 18: 69-75.
  7. 7. Peighambari SM, Gyles CL. Construction and characterization of avian E. coli cya crp mutants. Avian Dis. 1998; 42: 698-710.
  8. 8. Ghanbarpour R, Salehi M, Oswald E. Virulence genotyping of E. coli isolates from avian cellulites in relation to phylogeny. Comp Clin Pathol. 2010; 19: 147-153.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Publication Date

September 30, 2017

Submission Date

March 8, 2017

Acceptance Date

July 7, 2017

Published in Issue

Year 2017 Volume: 2 Number: 3

APA
Salama, S. (2017). Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization. Journal of Immunology and Clinical Microbiology, 2(3), 48-53. https://doi.org/10.5455/jicm.25-20170707
AMA
1.Salama S. Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization. J Immunol Clin Microbiol. 2017;2(3):48-53. doi:10.5455/jicm.25-20170707
Chicago
Salama, Selim. 2017. “Differentiation Between Vaccinal and Field Strains of E. Coli Using Phenotype and Genotype Characterization”. Journal of Immunology and Clinical Microbiology 2 (3): 48-53. https://doi.org/10.5455/jicm.25-20170707.
EndNote
Salama S (September 1, 2017) Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization. Journal of Immunology and Clinical Microbiology 2 3 48–53.
IEEE
[1]S. Salama, “Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization”, J Immunol Clin Microbiol, vol. 2, no. 3, pp. 48–53, Sept. 2017, doi: 10.5455/jicm.25-20170707.
ISNAD
Salama, Selim. “Differentiation Between Vaccinal and Field Strains of E. Coli Using Phenotype and Genotype Characterization”. Journal of Immunology and Clinical Microbiology 2/3 (September 1, 2017): 48-53. https://doi.org/10.5455/jicm.25-20170707.
JAMA
1.Salama S. Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization. J Immunol Clin Microbiol. 2017;2:48–53.
MLA
Salama, Selim. “Differentiation Between Vaccinal and Field Strains of E. Coli Using Phenotype and Genotype Characterization”. Journal of Immunology and Clinical Microbiology, vol. 2, no. 3, Sept. 2017, pp. 48-53, doi:10.5455/jicm.25-20170707.
Vancouver
1.Selim Salama. Differentiation between vaccinal and field strains of E. coli using phenotype and genotype characterization. J Immunol Clin Microbiol. 2017 Sep. 1;2(3):48-53. doi:10.5455/jicm.25-20170707

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM is a product of QMEL® medicine & publishing